Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach
Open Access
- 13 November 2006
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 68 (6), 1307-1314
- https://doi.org/10.1016/j.mehy.2006.07.058
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- PST 2238: A New Antihypertensive Compound that Modulates Na+,K+-ATPase and Antagonizes the Pressor Effect of OLFCardiovascular Drug Reviews, 2006
- OASIS-HT: Design of a Pharmacogenomic Dose-Finding StudyPharmacogenomics, 2005
- Cardiovascular Risk in Relation to α-Adducin Gly460Trp Polymorphism and Systolic PressureHypertension, 2005
- The α2-isoform of Na-K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitroAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Plasma Ouabain-Like Factor During Acute and Chronic Changes in Sodium Balance in Essential HypertensionHypertension, 2001
- Association of the α-adducin polymorphism with blood pressure and risk of myocardial infarctionJournal of Human Hypertension, 2000
- Adducin Polymorphism Affects Renal Proximal Tubule Reabsorption in HypertensionHypertension, 1999
- Ouabain-like Factor Quantification in Mammalian Tissues and PlasmaHypertension, 1997
- Renal Na,K-ATPase in Genetic HypertensionHypertension, 1996
- Association of the α-Adducin Locus With Essential HypertensionHypertension, 1995